Aspira Women's Health Investor Relations Material
Latest events
Q3 2024
Aspira Women's Health
Q1 2025
19 May, 2025
Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aspira Women's Health Inc
Access all reports
Aspira Women’s Health Inc. is a healthcare company focused on developing and commercializing diagnostic tools for women’s health, particularly in the areas of gynecologic disease and oncology. The company’s flagship products include advanced blood-based biomarker tests, such as those designed to assess ovarian cancer risk and improve early detection. Aspira Women’s Health is headquartered in Austin, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AWH
Country
🇺🇸 United States